Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.
about
Natural Products for the Treatment of Chlamydiaceae InfectionsVaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo.Microbiota composition of the koala (Phascolarctos cinereus) ocular and urogenital sites, and their association with Chlamydia infection and disease.Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR.Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.Diversity of Cervical Microbiota in Asymptomatic Chlamydia trachomatis Genital Infection: A Pilot Study.Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.Chlamydia trachomatis: The persistent pathogen.Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing.In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases.Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study.Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertility.The implausible "in vivo" role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota.Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis.Parallel detection of lactobacillus and bacterial vaginosis-associated bacterial DNA in the chorioamnion and vagina of pregnant women at term.Selection of validated hypervariable regions is crucial in 16S-based microbiota studies of the female genital tract.Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infectionBC5 Interferes With Infectivity Through Integrin Modulation in Cervical Cells
P2860
Q28066312-33DFFACF-F39A-49DC-8DC9-277CC84855F6Q33705063-3727470A-A8D0-44FA-A8BD-E29A80520D19Q33899564-0B03AEBD-7BD4-4E86-8E90-7780C8909CF9Q36282865-2C17862D-BFE8-4457-AF2E-E11536CB1856Q37627041-21D703F2-0DB0-43C2-836B-2143076574F9Q37833704-EC095EE8-1674-423B-B2E3-DB24B0E75E11Q39135146-68869D01-5008-423B-8973-75F243839EEBQ40082116-DDC90608-178B-4469-BDD3-7714A1646500Q44802067-32C4A9DC-77C4-480D-B30F-B41DE71D431DQ46250989-3BE7115F-CB37-4BB7-B78D-9F30415B1711Q47151734-FADB8D06-9D97-4B14-9BBD-1101A6ED218FQ47218414-0FD4651A-3FEB-41FD-A3DD-7FD4BB58612FQ48096223-B1E73088-3A8C-4A45-9FBD-E1C70AD7D7F6Q54237349-50166107-3A45-4451-A2BB-C24FB9EC8C05Q54267028-50C9AA29-D32E-4EDC-9069-05B575D5350AQ55512203-8A6A285C-6CAD-43A0-AC7C-4E1AD6C65E2CQ55562325-66CA37EF-BE74-4D3C-A99D-E01EC3198562Q56972974-F5C7093A-EB8A-4404-B7BC-C934BEA8039BQ59128363-6821715F-BE60-4219-8D67-B26542696F25
P2860
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lactobacillus crispatus inhibi ...... entary bodies, in vitro study.
@en
Lactobacillus crispatus inhibi ...... entary bodies, in vitro study.
@nl
type
label
Lactobacillus crispatus inhibi ...... entary bodies, in vitro study.
@en
Lactobacillus crispatus inhibi ...... entary bodies, in vitro study.
@nl
prefLabel
Lactobacillus crispatus inhibi ...... entary bodies, in vitro study.
@en
Lactobacillus crispatus inhibi ...... entary bodies, in vitro study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Lactobacillus crispatus inhibi ...... mentary bodies, in vitro study
@en
P2093
Beatrice Vitali
Claudio Foschi
Paola Nardini
Roberto Cevenini
P2860
P2888
P356
10.1038/SREP29024
P407
P577
2016-06-29T00:00:00Z